Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN Novartis (Press Release) 36m
Veradermics oral, extended-release minoxidil shows efficacy in female hair loss Scrip Pharma Intelligence 12h
Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy Pharmaceutical Technology 15h Biotech Biotechnology
Mandrake Bio raises Rs 16 crore to build AI-powered gene-editing platform for agriculture, medicine The Economic Times 18h AI CRISPR/Gene Editing Biotechnology
